Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The NIHR have today launched the fourth round of their Clinical Trials Fellowships (CTFs) competition. These fellowships are designed to support existing NIHR Trainees with an interest in, and experience of, working with clinical trials as part of their current training award who would benefit from further training within the setting of a Clinical Trial Unit (CTU) that is in receipt of NIHR CTU Support Funding.

The competition allows OCTRU to submit up to two applications with eligible individuals interested in applying for one of these fellowships. 

Anyone holding one of the following awards is eligible to apply:

  • NIHR Doctoral Research Fellowship (DRF);
  • NIHR Postdoctoral Fellowship (PDF);
  • NIHR Career Development Fellowship (CDF);
  • NIHR Clinical Lectureship (CL) (part of NIHR’s Integrated Academic Training Programme, including NIHR recognised locally-funded CLs);
  • NIHR Clinician Scientist Award;
  • NIHR Clinical Academic Training Doctoral Research Fellowship (CAT DRF);
  • NIHR Clinical Academic Training Clinical Lectureship (CAT CL);
  • NIHR Healthcare Scientist Doctoral Research Fellowship (HCS DRF);
  • NIHR Healthcare Scientist Postdoctoral Research Fellowship (HCS PDF).

In addition an individual must:

  • · Be involved in a clinical trial as part of their training award;
  • · Have an award that finishes on or after 1st February 2016; and
  • · Have continued support from their employing organisation for the duration of the fellowship (this will be the host institution that administers their current award and may or may not be the same as the institution that hosts the CTU).

As a CTU we would offer a training programme that would expose trainees to all aspects/stages of trials across trials on the OCTRU portfolio. 

If you are interesting in discussing a potential application, please email octrutrialshub@ndorms.ox.ac.uk – applications must be submitted to the NIHR by 17:00 on Friday 21st August 2015.

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.